SCHEMBL485062

SCHEMBL485062

Cc1ccc(C(C(=O)C(c2ccc(C)cc2)c2cc(Cl)c(O)cc2O)c2cc(Cl)c(O)cc2O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.42
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
LMNA P02545 4/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HSP90AB1 P08238 1/20 0.36
TRPA1 O75762 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A2 P23975 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
CNR2 P34972 2/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10652795 0.87 LMNA (0.40) LMNAALDH1A1GAAHTTIDO1
SCHEMBL485336 0.84 HSP90AA1 (0.45) HSP90AA1NPC1RAB9AHSP90AB1CNR2
SCHEMBL484707 0.81 DPP4 (0.45) HSP90AA1AKR1C2LMNAALDH1A1GAA
SCHEMBL485191 0.79 HSP90AA1 (0.44) HSP90AA1LMNAHTTNPC1RAB9A
SCHEMBL1011525 0.77 HSP90AA1 (0.38) HSP90AA1AKR1C2AKR1C1LMNAALDH1A1
SCHEMBL31413333 0.71 KMT2A (0.57) LMNAALDH1A1GAAHTTTRPA1
SCHEMBL27622752 0.71 LMNA (0.46) HSP90AA1LMNAALDH1A1PDK1L3MBTL1
SCHEMBL10654587 0.70 HDAC3 (0.46) LMNAALDH1A1HTTCNR2KDM4E
SCHEMBL10652036 0.70 ACP3 (0.41) LMNAALDH1A1GAAHTTTRPA1
SCHEMBL10652757 0.67 ACP3 (0.41) POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314132-B2 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone and the intermediates for production thereof BIOTECHNOLOGIJOS INSTITUTAS (LT) 2012-11-20 US claimed
EP-2268626-B1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INST (LT) 2012-02-01 EP claimed
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2011-02-24 US claimed
EP-2268626-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF Biotechnologijos Institutas (LT) 2011-01-05 EP claimed
WO-2009134110-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2009-11-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 HSP90AA1 3/4885AKR1C2 1751/4885AKR1C1 1656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.